+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free
Published Date: 2014-09-05Number of Pages: 80

Digital Pathology Systems Market (By Technology - Virtual Microscopy, Telepathology (Static Telepathology and Dynamic Telepathology); By Applications - Drug Discovery and Development, Disease Diagnosis and Academic Research) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

 

Digital pathology is an image based environment that involves managing, analyzing and interpreting digital information contained in a glass slide. Digital pathology is an emerging technology which offers substantial improvement in various applications such as drug discovery and development, diagnostic tests and academic and research purposes. Digital pathology is emerging at a rapid pace in the healthcare industry and is expected to overcome challenges in clinical practices, research and medical education. Advancements in information technology that enhances the prospects of improved connectivity and increasing favorable healthcare reforms are the major reasons that accentuate the uptake of digital pathology systems market. In addition, increasing workload of pathologists and rising healthcare spending has triggered the growth of digital pathology systems market globally. However, sampling error, high initial setup cost and stringent regulatory compliance might hamper the approval process of these systems and thereby reduce the uptake of digital pathology systems. The global digital pathology systems market was valued at USD 228.9 million in 2013 and is estimated to reach an estimated value of USD 492.8 million in 2020, growing at a CAGR of 11.9% from 2014 to 2020. 

 

Based on technology, the digital pathology systems market is segmented as virtual microscopy and telepathology. In 2013, virtual microscopy segment contributed the largest market share and is expected to grow at the highest growth rate during the forecast period from 2014 to 2020. This growth was mainly attributed to digitization of microscopic slides coupled with increasing preference for utilization of virtual microscopy for disease diagnosis and drug discovery. 

 

In 2013, disease diagnosis application segment accounted for the largest market share of the global digital pathology systems application market. This growth was mainly due to accurate and efficient diagnostic test results and rapidly analyzing slides in a short span of time with few diagnostic errors. However, increasing adoption rate of digital pathology among research communities for biomarker profiling and tumor morphological studies supports the growth of digital pathology systems in academic research application area during the study period from 2014 to 2020. 

 

Geographically, North America accounted for the largest market share of digital pathology systems market in 2013 and is expected to grow at a steady growth rate during the forecast period from 2014 to 2020. This market dominance was mainly due to increasing workload of pathologist, increasing use of companion diagnostics and favorable reimbursement policies. For instance, College of American Pathologist stated that, most of the computer assisted image analysis pathology tests are reimbursed under Medicare policy in the U.S. Europe accounted for the second largest market in 2013 and is expected to grow at the lowest CAGR during the study period due to economic downturn. Rising geriatric population in European Union is one of the major market drivers in this region as geriatric group are more prone to be diagnosed with cancer. 

 

Asia-Pacific is expected to grow at the highest CAGR from 2014 to 2020. This growth was mainly attributed to increasing geriatric population, rising healthcare awareness and increasing drug development activities in this region. For instance, in September 2013, Asia-Pacific International Academy of Pathology (APIAP) congress was held in Busan, South Korea. The primary agenda of this conference was utilization of pathology for the development of personalized medicine. The conference was hosted by the Korean division of IAP and countries participated includes Australia, China, Hong Kong, India, Indonesia, Japan, Korea, Pakistan, Philippines, Singapore, Taiwan and Thailand. Thus, arrangement of such conferences would help in increasing awareness in emerging economies. Moreover, companies are investing huge amount in Asian countries as these economies offer immense opportunities for the digital pathology systems on account of factors such as presence of large potential cancer patient population base coupled with continuous economic development. Major players operating in this market include Leica Biosystems, Olympus Corporation, Ventana Medical Systems, Inc., Philips Healthcare, GE Healthcare, Mikroscan Technologies, Inc. among others. 

 

 

 

Chapter 1 Introduction

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

      1.3.1 Secondary Research

      1.3.2 Primary Research

      1.3.3 Models

      1.3.4 Assumptions

1.4 List of Abbreviations

 

Chapter 2 Executive Summary

2.1 Market Snapshot: Global Digital Pathology Systems Market (2013 & 2020)

2.2 Global Digital Pathology Systems Market, by Technology, 2013 (USD Million)

2.3 Comparative Analysis: Global Digital Pathology Systems Market, by Geography, 2013 and 2020 (Value %)

 

Chapter 3 Market Overview

3.1 Overview

3.2 Event Impact Analysis: Global Digital Pathology Systems Market

3.3 Market Drivers

      3.3.1 The rising prevalence of cancer boosts digital pathology systems for diagnosis purpose

      3.3.2 Improvement in laboratory diagnostic accentuates the global demand of digital pathology systems

      3.3.3 Increasing workload on pathologists demands development of digital pathology systems

3.4 Restraints

      3.4.1 Strict regulatory requirement hold back (slows) the approval process of digital pathology and thereby affects the manufacturers for product commercialization

3.5 Opportunities

      3.5.1 Digital pathology systems hold immense potential in the anatomical pathology laboratories

      3.5.2 Rising cancer patient population augments the need of digital pathology in Asian economies

3.6 Value Chain Analysis

3.7 Porter’s Five Force Analysis: Global Digital Pathology Systems Market

      3.7.1 Bargaining power of suppliers

      3.7.2 Bargaining power of buyers

      3.7.3 Threat of new entrants

      3.7.4 Threat of substitutes

      3.7.5 Competitive rivalry

3.8 Market Attractiveness Analysis: Global Digital Pathology Systems Market, by Geography

3.9 Competitive Landscape

      3.9.1 Market Share Analysis by Key Players, 2013 (Value %)

 

Chapter 4 Digital Pathology Systems Market, by Technology

4.1 Overview

      4.1.1 Global Digital Pathology Systems Market Revenue, by Technology, 2012 – 2020 (USD Million)

4.2 Virtual Microscopy

      4.2.1 Global Virtual Microscopy Market Revenue, 2012 – 2020 (USD Million)

4.3 Telepathology

      4.3.1 Global Telepathology Market Revenue, by Types, 2012 – 2020 (USD Million)

      4.3.2 Static Telepathology

      4.3.3 Global Static Telepathology Market Revenue, 2012 – 2020 (USD Million)

      4.3.4 Dynamic Telepathology

      4.3.5 Global Dynamic Telepathology Market Revenue, 2012 – 2020 (USD Million)

 

Chapter 5 Digital Pathology Systems Market, by Application

5.1 Overview

      5.1.1 Global Digital Pathology Systems Market Revenue, by Applications, 2012 – 2020 (USD Million)

5.2 Drug Discovery and Development

      5.2.1 Global Drug Discovery and Development Application Market Revenue, 2012 – 2020 (USD Million)

5.3 Disease Diagnosis

      5.3.1 Global Disease Diagnosis Application Market Revenue, 2012 – 2020 (USD Million)

5.4 Academic Research

      5.4.1 Global Academic Research Application Market Revenue, 2012 – 2020 (USD Million)

 

Chapter 6 Digital Pathology Systems Market, by Geography

6.1 Overview

      6.1.1 Global Digital Pathology Systems Market Revenue, by Geography, 2012 – 2020 (USD Million)

6.2 North America

      6.2.1 North America Digital Pathology Systems Market Revenue, 2012 – 2020 (USD Million)

6.3 Europe

      6.3.1 Europe Digital Pathology Systems Market Revenue, 2012 – 2020 (USD Million)

6.4 Asia-Pacific

      6.4.1 Asia-Pacific Digital Pathology Systems Market Revenue, 2012 – 2020 (USD Million)

6.5 Rest of the World

      6.5.1 RoW Digital Pathology Systems Market Revenue, 2012 – 2020 (USD Million)

 

Chapter 7 Recommendations

7.1 Market Strategy for Success

      7.1.1 Investing in emerging markets to gain market share

      7.1.2 Mergers and acquisitions for sufficient market expansion

7.2 Barriers

      7.2.1 High initial setup cost and strict regulatory compliance pose a threat to the growth of this market

 

Chapter 8 Company Profiles

8.1 Digipath, Inc.

      8.1.1 Company Overview

      8.1.2 Financial Overview

      8.1.3 Product Portfolio

      8.1.4 Business Strategies

      8.1.5 Recent Developments

8.2 GE Healthcare

      8.2.1 Company Overview

      8.2.2 Financial Overview

      8.2.3 Product Portfolio

      8.2.4 Business Strategies

      8.2.5 Recent Developments

8.3 Leica Biosystems (Aperio Technologies, Inc.)

      8.3.1 Company Overview

      8.3.2 Financial Overview

      8.3.3 Product Portfolio

      8.3.4 Business Strategies

      8.3.5 Recent Developments

8.4 Mikroscan Technologies, Inc.

      8.4.1 Company Overview

      8.4.2 Financial Overview

      8.4.3 Product Portfolio

      8.4.4 Business Strategies

      8.4.5 Recent Developments

8.5 Olympus Corporation

      8.5.1 Company Overview

      8.5.2 Financial Overview

      8.5.3 Product Portfolio

      8.5.4 Business Strategies

      8.5.5 Recent Developments

8.6 Perkin Elmer, Inc.

      8.6.1 Company Overview

      8.6.2 Financial Overview

      8.6.3 Product Portfolio

      8.6.4 Business Strategies

      8.6.5 Recent Developments

8.7 Philips Healthcare

      8.7.1 Company Overview

      8.7.2 Financial Overview

      8.7.3 Product Portfolio

      8.7.4 Business Strategies

      8.7.5 Recent Developments

8.8 Ventana Medical Systems, Inc.

      8.8.1 Company Overview

      8.8.2 Financial Overview

      8.8.3 Product Portfolio

      8.8.4 Business Strategies

      8.8.5 Recent Developments

List of Figures

 

FIG. 1 Digital Pathology Systems : Market Segmentation

FIG. 2 Global Digital Pathology Systems Market, by Technology, 2013 (USD Million)

FIG. 3 Comparative Analysis: Global Digital Pathology Systems Market, by Geography, 2013 & 2020 (Value %)

FIG. 5 Porter’s Five Force Analysis: Global Digital Pathology Systems Market

FIG. 6 Market Attractiveness Analysis: Global Digital Pathology Systems Market, by Geography, 2013 Value (%)

FIG. 7 Market Share Analysis: Global Digital Pathology Systems Market, 2013  (Value %)

FIG. 8 Global Virtual Microscopy Market Revenue, 2012 – 2020 (USD Million)

FIG. 9 Global Static Telepathology Market Revenue, 2012 – 2020 (USD Million)

FIG. 10 Global Dynamic Telepathology Market Revenue, 2012 – 2020 (USD Million)

FIG. 11 Global Drug Discovery and Development Application Market Revenue, 2012 – 2020 (USD Million)

FIG. 12 Global Disease Diagnosis Application Market Revenue, 2012 – 2020 (USD Million)

FIG. 13 Global Academic Research Application Market Revenue, 2012 – 2020 (USD Million)

FIG. 14 North America Digital Pathology Systems Market Revenue, 2012 – 2020 (USD Million)

FIG. 15 Europe Digital Pathology Systems Market Revenue, 2012 – 2020 (USD Million)

FIG. 16 Asia-Pacific Digital Pathology Systems Market Revenue, 2012 – 2020 (USD Million)

FIG. 17 RoW Digital Pathology Systems Market Revenue, 2012 – 2020 (USD Million)

FIG. 18 GE Healthcare: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 19 Danaher Corporation: Annual Revenue (Life Science and Diagnostic), 2011 – 2013 (USD Million)

FIG. 20 Olympus Corporation: Annual Revenue (Life Science and Industrial), 2011 – 2013 (USD Million)

FIG. 21 Perkin Elmer, Inc.: Annual Revenue (Human Health Segment), 2011 – 2013 (USD Million)

FIG. 22 Philips Healthcare: Annual Revenue,2011 – 2013 (USD Million)

FIG. 23 F. Hoffmann-La Roche Ltd: Annual Revenue (Diagnostic), 2011 – 2013 (USD Million)

List of Tables

 

TABLE 1 List of Abbreviations

TABLE 2 Market Snapshot: Global Digital Pathology Systems Market (2013 & 2020)

TABLE 3 Global Digital Pathology Systems Market Revenue, by Technology, 2012 – 2020 (USD Million)

TABLE 4 Global Telepathology Market Revenue, 2012 – 2020 (USD Million)

TABLE 5 Global Digital Pathology Systems Market Revenue, by Applications, 2012 – 2020 (USD Million)

TABLE 6 Global Digital Pathology Systems Market Revenue, by Geography, 2012 – 2020 (USD Million)

Digital pathology systems are rapidly emerging within the healthcare industry and this technology has been offering tremendous improvement within numerous applications such as diagnostics tests, academic and research purposes, and drug discovery and development. These systems are gaining traction globally owing to their ability in effectively validating and identifying new drug candidates, building molecular therapies, categorizing patients for treatment purposes, and in assessing toxicology.

This research report on the digital pathology systems market has been compiled by conducting both primary and secondary research and includes data gathered from telephonic interviews, huge databases, and inputs from leading industry experts. The report presents various market dynamics such as growth prospects, drivers, opportunities, restraints, and challenges, and also states their respective effect on the market’s growth. 

The report presents an analysis of the market attractiveness and provides a Porter’s five forces evaluation for the market for digital pathology systems. The value chain distribution evaluation, starting from the raw material suppliers to end users such as clinical laboratories, hospitals, research organizations, and pharmaceutical companies, is also an integral part of this research study.

Overview of the Digital Pathology Systems Market

Digital pathology is an environment that is image-based and is enabled by computer technology. It comprises digitally analyzing, interpreting, and managing information that is contained within a glass slide. Owing to the advent of whole-slide imaging, the digital pathology field is becoming popular and is presently regarded as amongst the most lucrative avenue of diagnostic medicine for achieving accurate, cheaper, and fast diagnosis, and prediction and prognosis of diseases such as cancer, etc.

By technology, the market is led by the segment of virtual microscopy in 2013 and this segment is predicted to rise at the highest growth rate in the forecast horizon from 2014 to 2020. This is due to the increasing digitization of microscopic slides, along with the rising preference for virtual microscopy in drug discovery and disease diagnosis.

By application, the digital pathology systems market was led by the segment of disease diagnosis in 2013 and this segment is predicted to expand at a steady growth rate in the forecast horizon owing to favorable reimbursement policies.

Factors such as the advancements in information technology enhancing connectivity and rising favorable healthcare reforms are the prime reasons stimulating the market for digital pathology systems. Additionally, the increasing healthcare spending and rising workload of pathologists have further augmented the market for digital pathology systems. On the other hand, factors such as the high cost of initial setup, sampling errors, and strict regulatory compliance may impede approval for these systems, hence affecting the market negatively.

On the basis of geography, the market is segmented into Europe, North America, Asia Pacific, and Rest of the World (RoW). North America led the market in 2013 and is predicted to develop at a stable growth rate in the forecast horizon. This is due to the favorable policies of reimbursement and the rising workload of pathologists in the region. On the other hand, Asia Pacific is predicted to expand at the highest CAGR in the forecast horizon owing to increasing healthcare awareness, the rising aging population, and rising activities of drug development. 

Key players in the Digital Pathology Systems Market

The prime players dominant in the market are Olympus Corporation, Mikroscan Technologies, Inc., Leica Biosystems, Ventana Medical Systems, Inc., and GE Healthcare, among others.

Major geographies analyzed under this research report are: 

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World(RoW)

This report gives you access to decisive data such as:

  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for the coming years 

Key highlights of this report:

  • Overview of key market forces propelling and restraining market growth 
  • Up-to-date analyses of market trends and technological improvements
  • Pin-point analyses of market competition dynamics to offer you a competitive edge
  • An analysis of strategies of major competitors 
  • An array of graphics and SWOT analysis of major industry segments 
  • Detailed analyses of industry trends
  • A well-defined technological growth map with an impact-analysis 
  • Offers a clear understanding of the competitive landscape and key product segments


 
 
Back To Top